» Articles » PMID: 35950264

How Least Developed to Lower-Middle Income Countries Use Health Technology Assessment: A Scoping Review

Abstract

Health Technology Assessment (HTA) is a multidisciplinary tool to inform healthcare decision-making. HTA has been implemented in high-income countries (HIC) for several decades but has only recently seen a growing investment in low- and middle-income countries. A scoping review was undertaken to define and compare the role of HTA in least developed and lower middle-income countries (LLMIC). MEDLINE and EMBASE databases were searched from January 2015 to August 2021. A matrix comprising categories on HTA objectives, methods, geographies, and partnerships was used for data extraction and synthesis to present our findings. The review identified 50 relevant articles. The matrix was populated and sub-divided into further categories as appropriate. We highlight topical aspects of HTA, including initiatives to overcome well-documented challenges around data and capacity development, and identify gaps in the research for consideration. Those areas we found to be under-studied or under-utilized included disinvestment, early HTA/implementation, system-level interventions, and cross-sectoral partnerships. We consider broad practical implications for decision-makers and researchers aiming to achieve greater interconnectedness between HTA and health systems and generate recommendations that LLMIC can use for HTA implementation. Whilst HIC may have led the way, LLMIC are increasingly beginning to develop HTA processes to assist in their healthcare decision-making. This review provides a forward-looking model that LLMIC can point to as a reference for their own implementation. We hope this can be seen as timely and useful contributions to optimize the impact of HTA in an era of investment and expansion and to encourage debate and implementation.

Citing Articles

Health technology assessment capacity to support Zambia's health benefits package reform policy.

Simangolwa W, Govender K, Mbonigaba J Int J Technol Assess Health Care. 2025; 41(1):e15.

PMID: 40017134 PMC: 11894396. DOI: 10.1017/S0266462325000030.


Evidence quality and uncertainties considered in appraisal documents of drugs for rare diseases in England and Germany: a data extraction protocol.

Wiedmann L, Nolte E, Cairns J BMJ Open. 2025; 15(2):e089418.

PMID: 39956595 PMC: 11831311. DOI: 10.1136/bmjopen-2024-089418.


Assessing the development of health technology assessment in Iran: a policy analysis using Kingdon's Multiple streams framework: a qualitative study.

Behzadifar M, Shahabi S, Bakhtiari A, Azari S, Ehsanzadeh S, Yarahmadi M BMC Public Health. 2025; 25(1):226.

PMID: 39833814 PMC: 11745027. DOI: 10.1186/s12889-025-21465-5.


Systematic Review of Tools and Approaches for Evaluating the Transferability of Health Technology Assessments Across Different Jurisdictions.

Ahmadnezhad E, Kheirandish M, Akbari-Sari A, Rashidian A Int J Health Policy Manag. 2024; 13:8218.

PMID: 39620521 PMC: 11549564. DOI: 10.34172/ijhpm.8218.


Stakeholders' perspectives on disinvestment of low-value healthcare interventions and practices in Malaysia: an online survey.

Kamaruzaman H, Grieve E, Ku Abd Rahim K, Izzuna M, Sit Wai L, Romli E Int J Technol Assess Health Care. 2024; 40(1):e57.

PMID: 39544076 PMC: 11579699. DOI: 10.1017/S0266462324004665.


References
1.
Vassall A, Mangham-Jefferies L, Gomez G, Pitt C, Foster N . Incorporating Demand and Supply Constraints into Economic Evaluations in Low-Income and Middle-Income Countries. Health Econ. 2016; 25 Suppl 1:95-115. PMC: 5042074. DOI: 10.1002/hec.3306. View

2.
Chalkidou K, Towse A, Silverman R, Garau M, Ramakrishnan G . Market-driven, value-based, advance commitment (MVAC): accelerating the development of a pathbreaking universal drug regimen to end TB. BMJ Glob Health. 2020; 5(4). PMC: 7204919. DOI: 10.1136/bmjgh-2019-002061. View

3.
Schneider H, Maleka N . Patterns of authorship on community health workers in low-and-middle-income countries: an analysis of publications (2012-2016). BMJ Glob Health. 2018; 3(3):e000797. PMC: 5950650. DOI: 10.1136/bmjgh-2018-000797. View

4.
Elshaug A, Hiller J, Tunis S, Moss J . Challenges in Australian policy processes for disinvestment from existing, ineffective health care practices. Aust New Zealand Health Policy. 2007; 4:23. PMC: 2174492. DOI: 10.1186/1743-8462-4-23. View

5.
Dang A, Vallish B . Real world evidence: An Indian perspective. Perspect Clin Res. 2016; 7(4):156-160. PMC: 5079087. DOI: 10.4103/2229-3485.192030. View